TABLE 2.
Characteristics | Total, n = 95 (%) | Patients with CIN, n = 74 (%) | Patients with SCC, n = 21 (%) |
---|---|---|---|
Age (yr) | |||
≤70 | 44 (46) | 36 (49) | 8 (38) |
>70 | 51 (54) | 38 (51) | 13 (62) |
Sex | |||
Male | 75 (79) | 59 (80) | 16 (76) |
Female | 20 (21) | 15 (20) | 5 (24) |
Laterality | |||
OD | 42 (44) | 29 (39) | 13 (62) |
OS | 53 (56) | 45 (61) | 8 (38) |
Growth pattern | |||
Nodular | 78 (82) | 60 (81) | 18 (86) |
Diffuse | 15 (16) | 12 (16) | 3 (14) |
Multifocal | 2 (2) | 2 (3) | 0 (0) |
Tumor location | |||
Cornea/limbus | 73 (77) | 59 (80) | 14 (67) |
Bulbar conjunctiva | 93 (98) | 72 (97) | 21 (100) |
Tarsal conjunctiva | 7 (7) | 6 (8) | 1 (5) |
Fornix | 8 (8) | 7 (9) | 1 (5) |
Caruncle | 7 (7) | 4 (5) | 3 (14) |
Eyelid margin/lamella | 4 (4) | 3 (4) | 1 (5) |
Sclera | 2 (2) | 0 (0) | 2 (10) |
Biopsy | |||
Incisional | 21 (22) | 17 (23) | 4 (19) |
Excisional | 74 (78) | 57 (77) | 17 (81) |
Histopathologic grade | |||
Mid dysplasia (1/3) | — | 17 (23) | — |
Moderate dysplasia (2/3) | — | 12 (16) | — |
Severe dysplasia (3/3) | — | 45 (61) | — |
AJCC stage | |||
Tis | 74 (78) | 74 (100) | — |
T1 | 3 (3) | — | 3 (14) |
T2 | 2 (2) | — | 2 (10) |
T3 | 16 (17) | — | 16 (76) |